ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

KPRX Kiora Pharmaceuticals Inc

0.518
0.0047 (0.92%)
06 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Kiora Pharmaceuticals Inc KPRX NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.0047 0.92% 0.518 18:58:51
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.499 0.471 0.53749 0.521 0.5133
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
28/2/202415:40EDGAR2Form S-3 - Registration statement under Securities Act of..
14/2/202415:55EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202414:51EDGAR2Form D - Notice of Exempt Offering of Securities
13/2/202419:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202416:23EDGAR2Form 8-K - Current report
09/2/202415:16EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06/2/202409:27EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/2/202406:01EDGAR2Form 8-K - Current report
31/1/202416:14EDGAR2Form 8-K - Current report
16/1/202416:16EDGAR2Form 8-K - Current report
09/11/202306:02EDGAR2Form 8-K - Current report
09/11/202306:01EDGAR2Form 8-K - Current report
09/11/202306:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202305:05EDGAR2Form 8-K - Current report
13/10/202316:09EDGAR2Form S-8 - Securities to be offered to employees in employee..
03/10/202315:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202315:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202315:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202315:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202315:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202315:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202315:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202315:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202306:00EDGAR2Form 8-K - Current report
01/9/202306:00EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
01/9/202306:00EDGAR2Form 8-K - Current report
10/8/202316:23EDGAR2Form 3 - Initial statement of beneficial ownership of..
08/8/202306:14EDGAR2Form 8-K - Current report
08/8/202306:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/8/202306:00EDGAR2Form 8-K - Current report
21/7/202315:49EDGAR2Form DEF 14A - Other definitive proxy statements
20/7/202316:01EDGAR2Form 8-K - Current report
11/7/202316:00EDGAR2Form PRE 14A - Other preliminary proxy statements
23/6/202307:35GLOBELife Science Investor Forum: Presentations Now Available for..
20/6/202309:58GLOBELife Science Investor Forum Agenda Announced for June 22nd

Su Consulta Reciente

Delayed Upgrade Clock